Meerwijk Charlotte L L I van, Edema Astrid B, Rijn Laurentius J van, Los Leonoor I, Jansonius Nomdo M
Department of Ophthalmology, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Department of Ophthalmology, Amsterdam University Medical Center, location VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands.
J Clin Med. 2023 Mar 12;12(6):2200. doi: 10.3390/jcm12062200.
Secondary glaucoma is still a blinding complication in childhood uveitis, for which most commonly used surgical interventions (trabeculectomy or glaucoma drainage implant) involve multiple re-interventions and/or complications postoperatively. The goniotomy procedure has never been investigated in the current era, in which patients with pediatric uveitis receive biologics as immunosuppressive therapy for a prolonged period, with potential implications for the outcome. The purpose of the study is to evaluate the efficacy and safety of a goniotomy procedure in pediatric non-infectious uveitis in a retrospective, multicenter case series. The primary outcomes were the postoperative intraocular pressure (IOP), number of IOP-lowering medications, and success rate. Postoperative success was defined as 6 ≤ IOP ≤ 21 mmHg, without major complications or re-interventions. Fifteen eyes of ten children were included. Median age of the included patients at goniotomy was 7 years; median follow-up was 59 months. Median (interquartile range) IOP before surgery was 30 (26-34) mmHg with 4 (3-4) IOP-lowering medications. At 1, 2, and 5 years after goniotomy, median IOP was 15, 14, and 15 mmHg with 2 (0-2), 1 (0-2), and 0 (0-2) medications, respectively ( < 0.001 postoperatively versus preoperatively for all timepoints). Success rate was 100%, 93%, and 80% after 1, 2, and 5 years, respectively. There were no significant changes in visual acuity and uveitis activity or its treatment, and there were no major complications. Our results show that the goniotomy is an effective and safe surgery for children with uveitic glaucoma.
继发性青光眼仍是儿童葡萄膜炎导致失明的一种并发症,针对该病症,最常用的手术干预措施(小梁切除术或青光眼引流植入物)术后常需多次再次干预和/或出现并发症。在当前时代,从未对前房角切开术进行过研究,在这个时代,患有儿童葡萄膜炎的患者长期接受生物制剂作为免疫抑制治疗,这可能会对治疗结果产生影响。本研究的目的是在一项回顾性多中心病例系列研究中评估前房角切开术治疗儿童非感染性葡萄膜炎的疗效和安全性。主要结局指标为术后眼压(IOP)、降低眼压药物的使用数量和成功率。术后成功定义为眼压6≤IOP≤21 mmHg,无重大并发症或再次干预。纳入了10名儿童的15只眼。接受前房角切开术时纳入患者的中位年龄为7岁;中位随访时间为59个月。手术前眼压中位数(四分位间距)为30(26 - 34)mmHg,使用4(3 - 4)种降低眼压药物。在前房角切开术后1年、2年和5年,眼压中位数分别为15 mmHg、14 mmHg和15 mmHg,使用药物数量分别为2(0 - 2)种、1(0 - 2)种和0(0 - 2)种(所有时间点术后与术前相比,P<0.001)。1年、2年和5年后的成功率分别为100%、93%和80%。视力、葡萄膜炎活动度或其治疗均无显著变化,也无重大并发症。我们的结果表明,前房角切开术对于患有葡萄膜炎性青光眼的儿童是一种有效且安全的手术。